Sensus Healthcare, Inc.
Close on Oct 19, 2026
- Market cap
- $45.44M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 5, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 13, 2026 | During market hours | $2.30M | $-0.53 | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 7, 2026 | During market hours | $3.40M | $-0.16 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 12, 2026 | During market hours | $4.90M | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 6, 2025 | During market hours | $6.90M | $-0.06 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 7, 2025 | During market hours | $7.30M | $-0.06 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 15, 2025 | During market hours | $8.30M | $-0.16 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 5, 2025 | During market hours | $13.10M | $0.09 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 14, 2024 | Before market open | $8.80M | $0.07 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 8, 2024 | During market hours | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 9, 2024 | During market hours | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 8, 2024 | During market hours | – | – | – |
Company guidance
Outlook given with results on May 15, 2025, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| additional multisite FDA customers | this year | 3 to 5 | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Sensus Healthcare filed with the SEC
Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights
Results of operations · EX-99.1 to Form 8-K
Healthcare Reports First Quarter 2026 Financial Results and Business Highlights
Results of operations · EX-99.1 to Form 8-K
Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma
Results of operations · EX-99.1 to Form 8-K
Sensus Healthcare Reports Third Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Healthcare Reports Second Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Healthcare Reports First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Sensus Healthcare Buys Back Shares
Other events · EX-99.1 to Form 8-K
Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED NOVEMBER 17, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED NOVEMBER 14, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED AUGUST 8, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED MAY 9, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED FEBRUARY 8, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED NOVEMBER 9, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED AUGUST 3, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED MAY 3, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED FEBRUARY 9, 2023
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED JANUARY 5, 2023.
Results of operations · Executive or director change · EX-99.1 to Form 8-K
PRESS RELEASE, DATED NOVEMBER 3, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED AUGUST 4, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED MAY 5, 2022
Results of operations · EX-99.1 to Form 8-K
PRESSRELEASE, DATED MARCH 9, 2022
Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED FEBRUARY 10, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED JANUARY 5, 2022
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE, DATED NOVEMBER 4, 2021
Results of operations · EX-99.1 to Form 8-K